mobile-logo

December 2024

17 Dec

News update from Physiomics December 2024

by Charmaine Fraser
in Blog
Comments

Leading mathematical modelling company, supporting oncology drug development.   A Transformative Year at Physiomics - Innovation, Collaboration and Success   As 2024 draws to a close, we’re taking a moment to look back on an incredible year at Physiomics plc. From strengthening collaborations with global leaders to expanding our capabilities and welcoming fantastic new talent to the team, it’s been a year of exciting progress, working alongside leaders in...

Read More
13 Dec

Contract Award

by Charmaine Fraser
in Investor News / RNS
Comments

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contract with its long-standing client, Numab Therapeutics AG.   The project will involve the application of Pharmacokinetic-Pharmacodynamic (PK/PD) modelling to inform the Target Candidate Profile (“TCP”) of a key asset in Numab Therapeutic’ pipeline. Delivery of the project...

Read More
05 Dec

Contract Award

by Charmaine Fraser
in Investor News / RNS
Comments

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is delighted to announce it has been awarded a new contract with a long-standing, globally recognised pharmaceutical client. The project, valued at £157k, will leverage Physiomics’ expertise in Pharmacokinetic-Pharmacodynamic (“PKPD”) modelling to inform critical pre-clinical and clinical dosing and scheduling decisions for a...

Read More
04 Dec

Genesis 2024 Conference

by Charmaine Fraser
in Events
Comments

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce its attendance at the Genesis 2024 Conference, being held today, 4th December 2024, in London, UK.    Genesis, delivered by One Nucleus, is a premier event for the life sciences sector bringing together global leaders in drug development, investment, and innovation....

Read More